Case Report

Retiform Hemangioendothelioma Originating in the Paranasal Sinus: A Case Report

Keun-Ik Yi1, Myoung Joo Kang2, Kyung Han Nam3, Yong Wan Kim1,*
Author Information & Copyright
1Department of Otorhinolaryngology-Head & Neck Surgery, Inje University Haeundae Paik Hospital, Busan, Korea
2Division of Oncology, Department of Internal Medicine, Inje University Haeundae Paik Hospital, Busan, Korea
3Department of Pathology, Inje University Haeundae Paik Hospital, Busan, Korea
*Corresponding author: Yong Wan Kim, Department of Otorhinolaryngology-Head & Neck Surgery, Inje University Haeundae Paik Hospital, Busan 48108, Korea, Tel: +82-51-797-2290, Fax: +82-51-797-2304, E-mail:

© Copyright 2022 xxxxxxxxxxxxxxx. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Apr 19, 2022; Revised: May 16, 2022; Accepted: Oct 17, 2022

Published Online: Dec 31, 2022


Retiform hemangioendothelioma (RHE) is an extremely rare low-grade variant of angiosarcoma that mostly involves the dermis or subcutaneous tissue, but which has never been reported in paranasal sinus. A 53-year-old woman with the problems of a palpable lump on the left lower eyelid and anosmia visited to our hospital. An expansile mass was observed in the left frontoethmoid sinus in radiologic images, which was suspected to be attributable to bony erosion of the orbital wall and intracranial expansion. Endoscopic sinus surgery was performed to remove the mass. Histopathologically, tissues were infiltrated by arborizing vessels arranged in a retiform pattern. The immunohistochemistry also showed a positive result for CD31 and a partial positive for Ki-67. Because the recurrence was suspected 4 months after surgery, chemoradiotherapy following second operation was performed. Ultimately, we report a rare case of RHE in the nasal cavity.

Keywords: Vascular neoplasms; Retiform hemangioendothelioma; Paranasal Sinuses; Chemoradiotherapy


Since the term hemangioendothelioma (HE) was first used by Mallory1) in 1908, its definition has been changed over time by several authors. Recently, as proposed by Weiss and Enzinger2) in 1982, the definition of HE has been limited to vascular neoplasms showing a borderline biological behavior intermediate existing between entirely benign hemangiomas and highly malignant angiosarcomas. The category of this disease includes spindle cell HE, papillary angioendothelioma, epithelioid HE, kaposiform HE, pseudomyogenic HE, composite HE (CHE), and retiform HE (RHE). Definitive diagnosis among the various types of this disease is based on histopathological morphology and immunohistochemical markers.3) RHE was described by Calonje et al.4) in 1994, where it was to be considered a type of HE with a low rate of metastasis and a high rate of local recurrence. It is known to occur mainly in the upper and lower extremities, the trunk, and the head and neck area, but it is never reported in the paranasal sinus. To our knowledge, this is the first study to report the observation of RHE in the nasal cavity.

Case Report

A 53-year-old woman visited the ophthalmology outpatient clinic with a problem of a palpable lump on the medial side of the left lower eyelid for several years. The mass was painless and exhibited no change in size, so it has been observed without treatment. Symptoms of olfactory dysfunction appeared 3 months earlier. She experienced complete loss of left visual acuity due to trauma 30 years ago. On ophthalmologic examination, the left eyeball was displaced in the superolateral direction, and its movement was impaired; however, she was not aware of the time of onset. She had no past history except hypertension.

On contrast-enhanced computed tomography (CT), an expansile heterogenously intensely enhancing mass was observed in the left frontoethmoid sinus, which was accompanied by bony erosion of the orbital wall, and intracranial extension was suspected. Moreover, an ill-defined infiltrative soft tissue lesion in the extraconal and intraconal spaces of the left orbit was shown to extend to the periorbital area, which was considered to be a type of venolymphatic malformation (Fig. 1). Orbit magnetic resonance imaging (MRI) showed that the lesion located in the ethmoid sinus had low T1 and high T2 signals with good gadolinium enhancement, containing hemorrhage component and curvilinear T1/T2 dark signal (Fig. 2).

Fig. 1. Contrast-enhanced axial (A) and coronal (B) computed tomography (CT) of paranasal sinus shows expansile heterogenously intensely enhancing mass in left frontoethmoid sinus with orbital bulging and bony erosion. There were also ill-defined infiltrative soft tissue lesions in the extraconal and intraconal spaces of the left orbit, which were considered a type of venolymphatic malformation (white arrow).
Download Original Figure
Fig. 2. Gadolinium-enhanced T1 weighted (A) and T2 weighted (B) images on magnetic resonance imaging (MRI). Expansile lesion occupying left ethmoid sinus with orbital bulging shows low T1 signal and high T2 signal with good gadolinium enhancement, containing hemorrhage component and curvilinear T1/T2 dark signal.
Download Original Figure

A biopsy was performed under local anesthesia for neoplastic lesions observed in the left conjunctiva by ophthalmology. On pathologic examination, multiple dilated lymphatic channels of variable sizes with lymphocytic infiltration were observed, which was suggestive of lymphangiectasia. The mass located on the lower eyelid was judged to be the same as the tumor in the sinus cavity, so the patient was referred to the otorhinolaryngology for evaluation and treatment of the sinus tumor. A hemorrhagic polyp was found in front of the uncinate process on the nasal endoscopy (Fig. 3A). An endoscopic biopsy was performed under local anesthesia at an outpatient clinic. Hemangioma was suspected in the form of closely packed vascular structures without any malignant features in the pathologic report.

Fig. 3. Preoperative nasal endoscopic findings. A: Preoperative nasal endoscopy shows a hemorrhagic polyp in front of the uncinate process (arrow). B: Recurrence is suspected by nasal endoscopy 4 months after surgery (arrow).
Download Original Figure

For the lesion, which was confirmed as intraorbital lymphangiectasia, it was decided not to perform surgical resection due to the burden of orbital extraction. On the other hand, left endoscopic sinus surgery was planned under general anesthesia to remove the tumor located in the nasal cavity and sinuses. Vascular embolization was performed in the distal part of the left internal maxillary artery the day before surgery due to the possibility of intraoperative massive hemorrhage. During surgery, a mass lesion extending from the anterior ethmoid sinuses to the periorbita, frontal sinus, and anterior skull base was observed. Further, the tumor was encapsulated and accompanied by organizing hematoma in appearance. The tumor was fragile, and it was removed in a piecemeal manner. The lamina papyracea and skull base bone were partially lost due to the pressure effect on the tumor. A frozen biopsy was conducted to obtain benign findings.

Postoperative histopathological examination revealed vascular proliferation composed of interconnecting arborizing blood vessels arranged in a retiform pattern, which were lined by monomorphic, hobnail endothelial cells. No significant cytologic atypia or mitotic figures were identified. The tumor demonstrated prominent hemorrhage with ectatic vessels and mild lymphocytic infiltrate in the stroma (Fig. 4A, B). Moreover, the immunohistochemical stain results were positive for CD31 and D2-40 in endothelial cells (Fig. 4C). Ki-67 showed a low proliferation index in tumor cells (11%) (Fig. 4D). The lesion was negative for both HHV8 and neuroendocrine marker (synaptophysin, CD56). Based on these features, it could clearly be diagnosed as RHE.

Fig. 4. Histopathologic findings. A: Histopathological analysis with H&E staining shows an infiltrating neoplasm composed of elongated arborizing blood vessels arranged in anastomosing pattern resembling that of the rete testis (H&E staining, ×200). B: Neoplastic endothelial cells show monomorphic hobnail appearance without significant atypia (H&E staining, ×400). C: Neoplastic cells are reactive for endothelial cell marker, CD31 (immunohistochemistry staining, ×100). D: Ki-67 shows a low proliferation fraction of the tumor cells (immunohistochemistry staining, ×200).
Download Original Figure

Recurrence of nasal endoscopy appeared 4 months after surgery (Fig. 3B), so a second operation for volume reduction was performed followed chemoradiotherapy with cisplatin. There was no evidence of recurrence for 7 months after this treatment.


Most reported cases of RHE originate from cutaneous or superficial portions of the body, except for two cases of primary bone tumor reported by Aditya et al.5) and Kim et al.6) It occurred in the head and neck area in approximately 15% of cases, including scalp, canthus, pinna, parietal bones, and infratemporal fossa. To our knowledge, there have been no cases found in the nasal cavity.

Clinically, lesions of RHE appear as a solitary, slow-growing exo-endophytic mass, resulting in a characteristic of subcutaneous firm nodule.3) There has been a female predominance, but the remarkable predominant generation has yet to be defined.6)

The differential diagnosis of RHE includes Dabska’s tumor, malignant lymphoma, dermatofibrosarcoma protuberans, bacillary angiomatosis, Kaposi’s sarcoma, targetoid hemosiderotic hemangioma, and angiosarcoma.4,7) Histopathological examinations are needed to confirm the diagnosis of RHE it does not have unique clinical or radiological features. RHE consists of elongated arboreal vessels arranged in an anastomotic pattern in a manner similar to rete testis. Neoplastic vessels are lined with a single layer of hobnail-like endothelial cells protruding within the narrow lumina.3) Immunohistochemically, hobnail-like cells lining the elongated vascular space express endothelial markers, including von Willebrand factor, CD31, and CD34.8) Spindle cells in the solid region are positive for CD31 but negative for von Willebrand factor and CD34. Whether or not it responds to D2-40 remains controversial.9,10)

In our case, the area judged to be hemangioma was partially observed. It could be diagnosed as CHE because the tumor tissue had various vascular components. CHE—which is defined as a vascular neoplasm presenting combinations of benign, low-grade, and high-grade malignant components—was initially described by Nayler et al. in 2000.11) The most frequent histological component observed in CHE is retiform type, followed in order by epithelioid and spindle cell HE. Some benign components, such as cavernous hemangioma and arteriovenous malformations, may also be observed.12) However, the hemangioma-like area accounted for less than 10% of the total specimen in our case, so it is arguable whether it can be diagnosed as CHE. The definition of CHE still fails to provide both ‘minimal’ and ‘maximal’ criteria for diagnosis, and some published cases are better interpreted to be representing other tumors.13)

Although a definitive treatment option has yet to be established, surgical excision has been performed in most patients with RHE to this point. Hirsh et al.7) reported that chemoradiotherapy with low-dose cisplatin successfully treated RHE without surgical resection. Local recurrence is common; half of RHE has a mean recurrence period of about 12 months after surgery.6) However, metastasis is known to be rare. Even though RHE locally recurs with a high rate, no deaths have been reported. In our case, chemoradiotherapy was performed for local recurrent lesions after surgical attempt, and there has been no further evidence of recurrence to date. In the first operation of our case, endoscopic sinus surgery for biopsy was performed, and it is believed that a definitive treatment was not performed because the histological diagnosis was not certain. To reduce possible recurrence, there may be a need for an external approach with craniofacial resection.


In summary, RHE is a kind of low-grade malignant angiosarcoma with a high rate of local recurrence. Our case showed that it could occur in rare cases in the paranasal sinus, which should prompt accurate diagnosis and early intervention.


Not applicable.

Funding Information

Not applicable.

Conflicts of Interest

No potential conflict of interest relevant to this article was reported.

Author Contribution

Conceptualization: Kim YW.

Data curation: Yi KI.

Formal analysis: Kang MJ, Nam KH.

Methodology: Kang MJ, Nam KH.

Validation: Kang MJ, Nam KH.

Investigation: Yi KI.

Writing - original draft: Yi KI.

Writing - review & editing: Yi KI, Kang MJ, Nam KH, Kim YW.

Ethics Approval

Informed consent for publication of the images was obtained from the patient.



Mallory FB. The results of the application of special histological methods to the study of tumors. J Exp Med 1908;10(5):575-93.


Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma a vascular tumor often mistaken for a carcinoma. Cancer 1982;50(5):970-81.


Requena L, Kutzner H. Hemangioendothelioma. Semin Diagn Pathol 2013;30(1):29-44.


Calonje E, Fletcher C, Wilson-Jones E, Rosai J. Retiform hemangioendothelioma: a distinctive form of low-grade angiosarcoma delineated in a series of 15 cases. Am J Surg Pathol 1994;18(2):115-25.


Aditya GS, Santosh V, Yasha TC, Shankar SK. Epithelioid and retiform hemangioendothelioma of the skull bone -report of four cases. Indian J Pathol Microbiol 2003;46(4):645-9.


Kim IK, Cho HY, Jung BS, Pae SP, Cho HW, Seo JH, et al. Retiform hemangioendothelioma in the infratemporal fossa and buccal area: a case report and literature review. J Korean Assoc Oral Maxillofac Surg 2016;42(5):307-14.


Hirsh AZ, Yan W, Wei L, Wernicke AG, Parashar B. Unresectable retiform hemangioendothelioma treated with external beam radiation therapy and chemotherapy: a case report and review of the literature. Sarcoma 2010;2010:756246.


Dufau JP, Pierre C, De Saint Maur PP, Bellavoir A, Gros P. Retiform hemangioendothelioma. Ann Pathol 1997;17(1):47-51.


Liu Q, Ouyang R, Chen P, Zhou R. A case report of retiform hemangioendothelioma as pleural nodules with literature review. Diagn Pathol 2015;10:194.


Parsons A, Sheehan DJ, Sangueza OP. Retiform hemangioendotheliomas usually do not express D2-40 and VEGFR-3. Am J Dermatopathol 2008;30(1):31-3.


Nayler SJ, Rubin BP, Calonje E, Chan JK, Fletcher CD. Composite hemangioendothelioma: a complex, low-grade vascular lesion mimicking angiosarcoma. Am J Surg Pathol 2000;24(3):352-61.


Li WW, Liang P, Zhao HP, Zhang YX, Liu YY, Gao JB. Composite hemangioendothelioma of the spleen with multiple metastases: CT findings and review of the literature. Medicine 2021;100(21):e25846.


Goldblum JR, Folpe AL, Weiss SW. Enzinger and Weiss’s soft tissue tumors e-book. Philadelphia, PA: Elsevier; 2020.